Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890298405> ?p ?o ?g. }
- W2890298405 endingPage "325" @default.
- W2890298405 startingPage "317" @default.
- W2890298405 abstract "Ipilimumab was the first immunotherapy approved for metastatic melanoma in decades and is currently registered as a second-line treatment. However, new immunotherapies, in combination with ipilimumab, offer even better clinical outcomes for patients compared with single-agent treatments, at the expense of improved toxicity. The aim of this study was to evaluate the feasibility of ipilimumab outside the clinical trials and to identify survival predictors for treatment benefit. Data were collected on 47 advanced melanoma patients treated with ipilimumab between 2010 and 2015 at a single center. Association of clinical characteristics (including primary tumor characteristics), serum lactate dehydrogenase (LDH), erythrocyte sedimentation rate, absolute eosinophil, lymphocyte, and neutrophil count, neutrophil/lymphocyte and eosinophil/lymphocyte ratio with toxicity and clinical outcome were assessed using univariate and multivariate analysis. Median progression-free survival at a median follow-up of 10 months was 2.7 months and median overall survival was 9.8 months. Objective response was observed in 17% of patients and the disease control rate at week 24 was 40%. The 1- and 2-year survival rates documented were 40 and 28%, respectively. Significant association between high LDH level (>1.5× upper limit of normal) and decreased overall survival was demonstrated in uni- and multivariate analysis (hazard ratio [HR]: 3.554, 95% CI: 1.225–10.306, p = 0.019). Neither biomarkers nor clinical outcome were associated with toxicity. Using baseline serum LDH to identify patients most likely to benefit from ipilimumab therapy could serve as a simple and inexpensive biomarker of clinical outcome." @default.
- W2890298405 created "2018-09-27" @default.
- W2890298405 creator A5011197831 @default.
- W2890298405 creator A5032211944 @default.
- W2890298405 creator A5067563487 @default.
- W2890298405 creator A5074451850 @default.
- W2890298405 creator A5075559392 @default.
- W2890298405 creator A5078366605 @default.
- W2890298405 creator A5080670372 @default.
- W2890298405 creator A5084858996 @default.
- W2890298405 creator A5091287620 @default.
- W2890298405 date "2018-09-17" @default.
- W2890298405 modified "2023-10-17" @default.
- W2890298405 title "Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab" @default.
- W2890298405 cites W1499291662 @default.
- W2890298405 cites W1581074935 @default.
- W2890298405 cites W1870093969 @default.
- W2890298405 cites W1919200564 @default.
- W2890298405 cites W1936755024 @default.
- W2890298405 cites W1965215390 @default.
- W2890298405 cites W1967084952 @default.
- W2890298405 cites W1979651049 @default.
- W2890298405 cites W1982906652 @default.
- W2890298405 cites W1997919830 @default.
- W2890298405 cites W2000583779 @default.
- W2890298405 cites W2017381571 @default.
- W2890298405 cites W2027516399 @default.
- W2890298405 cites W2037801848 @default.
- W2890298405 cites W2042293669 @default.
- W2890298405 cites W2042576421 @default.
- W2890298405 cites W2054535181 @default.
- W2890298405 cites W2056199226 @default.
- W2890298405 cites W2056918351 @default.
- W2890298405 cites W2070825440 @default.
- W2890298405 cites W2070871778 @default.
- W2890298405 cites W2085458222 @default.
- W2890298405 cites W2089536793 @default.
- W2890298405 cites W2097025111 @default.
- W2890298405 cites W2097995306 @default.
- W2890298405 cites W2100158834 @default.
- W2890298405 cites W2103220202 @default.
- W2890298405 cites W2107863654 @default.
- W2890298405 cites W2109465910 @default.
- W2890298405 cites W2109545379 @default.
- W2890298405 cites W2117692326 @default.
- W2890298405 cites W2128758225 @default.
- W2890298405 cites W2133075384 @default.
- W2890298405 cites W2137298764 @default.
- W2890298405 cites W2141269240 @default.
- W2890298405 cites W2151507811 @default.
- W2890298405 cites W2158299227 @default.
- W2890298405 cites W2163188200 @default.
- W2890298405 cites W2164376903 @default.
- W2890298405 cites W2166667372 @default.
- W2890298405 cites W2175859432 @default.
- W2890298405 cites W2282962877 @default.
- W2890298405 cites W2328314409 @default.
- W2890298405 cites W2523880687 @default.
- W2890298405 cites W4230728952 @default.
- W2890298405 doi "https://doi.org/10.1007/s12253-018-0466-9" @default.
- W2890298405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30225783" @default.
- W2890298405 hasPublicationYear "2018" @default.
- W2890298405 type Work @default.
- W2890298405 sameAs 2890298405 @default.
- W2890298405 citedByCount "19" @default.
- W2890298405 countsByYear W28902984052018 @default.
- W2890298405 countsByYear W28902984052019 @default.
- W2890298405 countsByYear W28902984052020 @default.
- W2890298405 countsByYear W28902984052021 @default.
- W2890298405 countsByYear W28902984052022 @default.
- W2890298405 countsByYear W28902984052023 @default.
- W2890298405 crossrefType "journal-article" @default.
- W2890298405 hasAuthorship W2890298405A5011197831 @default.
- W2890298405 hasAuthorship W2890298405A5032211944 @default.
- W2890298405 hasAuthorship W2890298405A5067563487 @default.
- W2890298405 hasAuthorship W2890298405A5074451850 @default.
- W2890298405 hasAuthorship W2890298405A5075559392 @default.
- W2890298405 hasAuthorship W2890298405A5078366605 @default.
- W2890298405 hasAuthorship W2890298405A5080670372 @default.
- W2890298405 hasAuthorship W2890298405A5084858996 @default.
- W2890298405 hasAuthorship W2890298405A5091287620 @default.
- W2890298405 hasConcept C121608353 @default.
- W2890298405 hasConcept C126322002 @default.
- W2890298405 hasConcept C143998085 @default.
- W2890298405 hasConcept C144237770 @default.
- W2890298405 hasConcept C148220186 @default.
- W2890298405 hasConcept C2777658100 @default.
- W2890298405 hasConcept C2777701055 @default.
- W2890298405 hasConcept C2781433595 @default.
- W2890298405 hasConcept C33923547 @default.
- W2890298405 hasConcept C502942594 @default.
- W2890298405 hasConcept C71924100 @default.
- W2890298405 hasConceptScore W2890298405C121608353 @default.
- W2890298405 hasConceptScore W2890298405C126322002 @default.
- W2890298405 hasConceptScore W2890298405C143998085 @default.
- W2890298405 hasConceptScore W2890298405C144237770 @default.
- W2890298405 hasConceptScore W2890298405C148220186 @default.
- W2890298405 hasConceptScore W2890298405C2777658100 @default.